top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjcvp

Abstract Aims We compared clinical outcomes in patients with AF with and without diabetes in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Justin A. Ezekowitz, Basil S. Lewis, Renato D. Lopes, Daniel M. Wojdyla, John J.V. McMurray, Michael Hanna, Dan Atar, M. ...

Date : 01/04/2015 Item size : 304584 bytes
Ehjournal

Abstract Aims The prognostic implication of adiposity on clinical outcomes in atrial fibrillation (AF) patients treated with oral anticoagulation is unclear. Methods and results A total of 17 913 ...

European Heart Journal, Clinical Research, Roopinder K. Sandhu, Justin Ezekowitz, Ulrika Andersson, John H. Alexander, Christopher B. Granger, Sigrun Halvorsen, Michael Hanna, Ziad Hijazi, Petr ...

Date : 07/10/2016 Item size : 315464 bytes
Ehjournal

Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial Methods and results ...

European Heart Journal, CLINICAL RESEARCH, Dragos Vinereanu, Susanna R. Stevens, John H. Alexander, Sana M. Al-Khatib, Alvaro Avezum, Marıa Cecilia Bahit, Christopher B. Granger, Renato D. Lopes, ...

Date : 07/12/2015
Ehjournal

Abstract Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke, major bleed, ...

European Heart Journal, Thrombosis and antithrombotic therapy, Claes Held, Elaine M. Hylek, John H. Alexander, Michael Hanna, Renato D. Lopes, Daniel M. Wojdyla, Laine Thomas, Hussein Al-Khalidi, ...

Date : 21/05/2015